{"id":123281,"name":"ORASURE TECHNOLOGIES INC","slug":"orasure-technologies-inc","state":"PA","country":"United States of America","description":"","totalSpending":360000,"filings":36,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":40000},{"year":2023,"income":60000},{"year":2024,"income":50000},{"year":2025,"income":40000}],"issues":["BUD","HCR"],"firms":["HEALTH AND MEDICINE COUNSEL, LLC"],"lobbyists":["DALE DIRKS","DANE CHRISTIANSEN","PHILIP GOGLAS","KIRA FLAHERTY"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","State, Dept of (DOS)"],"sampleDescriptions":["FY18 L-HHS Appropriations Bill \n\n FY18 MilCon-VA \n\nFY18 State and Foreign Ops. Bill \n\nFY18 DoD \n\nViral Hepatitis Testing Act\n\nGrants (HIV & Hepatitis)\n\nHepatitis C & the VA","Viral Hepatitis/HIV/AIDS \n\nHep Action Plan \n\nViral Hepatitis Testing Act \n\nEbola Screening \n\nSubstance Abuse testing \n\nCMS Reimbursement","Viral Hepatitis/HIV/AIDS \n\nHep Action Plan \n\nViral Hepatitis Testing Act \n\nEbola Screening \n\nSubstance Abuse testing \n\nCMS Reimbursement\n\nVA HCV testing policy","FY19 L-HHS Appropriations Bill \n\nFY19 MilCon-VA \n\nFY19 State and Foreign Ops. Bill \n\nFY19 DoD \n\nViral Hepatitis Testing Act\n\nGrants (HIV & Hepatitis)\n\nHepatitis C & the VA","Viral Hepatitis/HIV/AIDS \n\nHep Action Plan \n\nViral Hepatitis Testing Act \n\nEbola Screening \n\nSubstance Abuse testing \n\nCMS Reimbursement\n\nVA HCV testing policy\n\nHR 5922"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}